Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0

M. Sakiyama, M. Kami, A. Hori, O. Imataki, T. Hamaki, N. Murashige, K. Kobayashi, Y. Kishi, R. Kojima, S. W. Kim, E. Kusumi, K. Yuji, S. Miyakoshi, S. Mori, Ryuji Tanosaki, S. Taniguchi, Y. Takaue

研究成果: Article

13 引用 (Scopus)

抄録

Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST. We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were significantly associated with the outcome confirming the predictive value of both the systems. A total of 15 patients died of disease progression, and 12 of transplant-related mortality: RRT (n=2), graft-versus-host disease (GVHD) (n=7), infection (n=1), and others (n=2). GVHD-related deaths primarily resulted from infections after steroid treatment (n=6) and bronchiolitis obliterans (n=1). This study shows that NCI-CTC is appropriate in toxicity evaluation of RIST, and that its application to RIST enables a toxicity comparison between RIST and other types of cancer treatments. Since GVHD is a significant problem in RIST, modifications are required to evaluate immunological complications following RIST.

元の言語English
ページ(範囲)787-794
ページ数8
ジャーナルBone Marrow Transplantation
34
発行部数9
DOI
出版物ステータスPublished - 2004 11
外部発表Yes

Fingerprint

National Cancer Institute (U.S.)
Stem Cell Transplantation
Neoplasms
Graft vs Host Disease
Bronchiolitis Obliterans
Transplants
Infection
Disease Progression
Transplantation
Steroids
Mortality
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Transplantation

これを引用

Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST) : Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0. / Sakiyama, M.; Kami, M.; Hori, A.; Imataki, O.; Hamaki, T.; Murashige, N.; Kobayashi, K.; Kishi, Y.; Kojima, R.; Kim, S. W.; Kusumi, E.; Yuji, K.; Miyakoshi, S.; Mori, S.; Tanosaki, Ryuji; Taniguchi, S.; Takaue, Y.

:: Bone Marrow Transplantation, 巻 34, 番号 9, 11.2004, p. 787-794.

研究成果: Article

Sakiyama, M, Kami, M, Hori, A, Imataki, O, Hamaki, T, Murashige, N, Kobayashi, K, Kishi, Y, Kojima, R, Kim, SW, Kusumi, E, Yuji, K, Miyakoshi, S, Mori, S, Tanosaki, R, Taniguchi, S & Takaue, Y 2004, 'Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0', Bone Marrow Transplantation, 巻. 34, 番号 9, pp. 787-794. https://doi.org/10.1038/sj.bmt.1704673
Sakiyama, M. ; Kami, M. ; Hori, A. ; Imataki, O. ; Hamaki, T. ; Murashige, N. ; Kobayashi, K. ; Kishi, Y. ; Kojima, R. ; Kim, S. W. ; Kusumi, E. ; Yuji, K. ; Miyakoshi, S. ; Mori, S. ; Tanosaki, Ryuji ; Taniguchi, S. ; Takaue, Y. / Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST) : Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0. :: Bone Marrow Transplantation. 2004 ; 巻 34, 番号 9. pp. 787-794.
@article{79635b18645947c9837d7385234ab488,
title = "Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0",
abstract = "Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST. We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were significantly associated with the outcome confirming the predictive value of both the systems. A total of 15 patients died of disease progression, and 12 of transplant-related mortality: RRT (n=2), graft-versus-host disease (GVHD) (n=7), infection (n=1), and others (n=2). GVHD-related deaths primarily resulted from infections after steroid treatment (n=6) and bronchiolitis obliterans (n=1). This study shows that NCI-CTC is appropriate in toxicity evaluation of RIST, and that its application to RIST enables a toxicity comparison between RIST and other types of cancer treatments. Since GVHD is a significant problem in RIST, modifications are required to evaluate immunological complications following RIST.",
keywords = "Graft-versus-host disease, NCI-CTC version 2.0, Reduced intensity stem-cell transplantation, Regimen-related toxicity",
author = "M. Sakiyama and M. Kami and A. Hori and O. Imataki and T. Hamaki and N. Murashige and K. Kobayashi and Y. Kishi and R. Kojima and Kim, {S. W.} and E. Kusumi and K. Yuji and S. Miyakoshi and S. Mori and Ryuji Tanosaki and S. Taniguchi and Y. Takaue",
year = "2004",
month = "11",
doi = "10.1038/sj.bmt.1704673",
language = "English",
volume = "34",
pages = "787--794",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST)

T2 - Comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0

AU - Sakiyama, M.

AU - Kami, M.

AU - Hori, A.

AU - Imataki, O.

AU - Hamaki, T.

AU - Murashige, N.

AU - Kobayashi, K.

AU - Kishi, Y.

AU - Kojima, R.

AU - Kim, S. W.

AU - Kusumi, E.

AU - Yuji, K.

AU - Miyakoshi, S.

AU - Mori, S.

AU - Tanosaki, Ryuji

AU - Taniguchi, S.

AU - Takaue, Y.

PY - 2004/11

Y1 - 2004/11

N2 - Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST. We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were significantly associated with the outcome confirming the predictive value of both the systems. A total of 15 patients died of disease progression, and 12 of transplant-related mortality: RRT (n=2), graft-versus-host disease (GVHD) (n=7), infection (n=1), and others (n=2). GVHD-related deaths primarily resulted from infections after steroid treatment (n=6) and bronchiolitis obliterans (n=1). This study shows that NCI-CTC is appropriate in toxicity evaluation of RIST, and that its application to RIST enables a toxicity comparison between RIST and other types of cancer treatments. Since GVHD is a significant problem in RIST, modifications are required to evaluate immunological complications following RIST.

AB - Acute regimen-related toxicity (RRT) is minimal in reduced-intensity stem-cell transplantation (RIST). However, the Seattle RRT grading (Bearman et al), developed in the context of conventional-intensity transplantation, is frequently applied to RIST. We compared the National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 2.0 with the Seattle criteria after RIST in 86 patients. RRT within 30 days of transplant graded by both sets of criteria were significantly associated with the outcome confirming the predictive value of both the systems. A total of 15 patients died of disease progression, and 12 of transplant-related mortality: RRT (n=2), graft-versus-host disease (GVHD) (n=7), infection (n=1), and others (n=2). GVHD-related deaths primarily resulted from infections after steroid treatment (n=6) and bronchiolitis obliterans (n=1). This study shows that NCI-CTC is appropriate in toxicity evaluation of RIST, and that its application to RIST enables a toxicity comparison between RIST and other types of cancer treatments. Since GVHD is a significant problem in RIST, modifications are required to evaluate immunological complications following RIST.

KW - Graft-versus-host disease

KW - NCI-CTC version 2.0

KW - Reduced intensity stem-cell transplantation

KW - Regimen-related toxicity

UR - http://www.scopus.com/inward/record.url?scp=7944223663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7944223663&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704673

DO - 10.1038/sj.bmt.1704673

M3 - Article

C2 - 15361909

AN - SCOPUS:7944223663

VL - 34

SP - 787

EP - 794

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -